Literature DB >> 1734522

DNA binding activity of recombinant SRY from normal males and XY females.

V R Harley1, D I Jackson, P J Hextall, J R Hawkins, G D Berkovitz, S Sockanathan, R Lovell-Badge, P N Goodfellow.   

Abstract

The protein encoded by the human testis determining gene, SRY, contains a high mobility group (HMG) box related to that present in the T cell-specific, DNA-binding protein TCF-1. Recombinant SRY protein was able to bind to the same core sequence AACAAAG recognized by TCF-1 in a sequence dependent manner. In five XY females point mutations were found in the region encoding the HMG box. In four cases DNA binding activity of mutant SRY protein was negligible; in the fifth case DNA binding was reduced. These results imply that the DNA binding activity of SRY is required for sex determination.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1734522     DOI: 10.1126/science.1734522

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  96 in total

1.  A direct role of SRY and SOX proteins in pre-mRNA splicing.

Authors:  Kenji Ohe; Enzo Lalli; Paolo Sassone-Corsi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

Review 2.  SRY protein function in sex determination: thinking outside the box.

Authors:  Liang Zhao; Peter Koopman
Journal:  Chromosome Res       Date:  2012-01       Impact factor: 5.239

3.  Mice null for sox18 are viable and display a mild coat defect.

Authors:  D Pennisi; J Bowles; A Nagy; G Muscat; P Koopman
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

4.  XY sex reversal associated with a deletion 5' to the SRY "HMG box" in the testis-determining region.

Authors:  K McElreavy; E Vilain; N Abbas; J M Costa; N Souleyreau; K Kucheria; C Boucekkine; E Thibaud; R Brauner; F Flamant
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

5.  Mutations in the conserved domain of SRY are uncommon in XY gonadal dysgenesis.

Authors:  E K Pivnick; S Wachtel; D Woods; J L Simpson; C E Bishop
Journal:  Hum Genet       Date:  1992-11       Impact factor: 4.132

6.  Modeling Huntington's disease in cells, flies, and mice.

Authors:  S Sipione; E Cattaneo
Journal:  Mol Neurobiol       Date:  2001-02       Impact factor: 5.590

7.  Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer.

Authors:  L Dailey; H Yuan; C Basilico
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

8.  Sex-specific neuroprotection by inhibition of the Y-chromosome gene, SRY, in experimental Parkinson's disease.

Authors:  Joohyung Lee; Paulo Pinares-Garcia; Hannah Loke; Seungmin Ham; Eric Vilain; Vincent R Harley
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-01       Impact factor: 11.205

9.  SRY protein enhances transcription of Fos-related antigen 1 promoter constructs.

Authors:  D R Cohen; A H Sinclair; J D McGovern
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

10.  Human Sex Determination at the Edge of Ambiguity: INHERITED XY SEX REVERSAL DUE TO ENHANCED UBIQUITINATION AND PROTEASOMAL DEGRADATION OF A MASTER TRANSCRIPTION FACTOR.

Authors:  Joseph D Racca; Yen-Shan Chen; Yanwu Yang; Nelson B Phillips; Michael A Weiss
Journal:  J Biol Chem       Date:  2016-08-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.